Rani Therapeutics Holdings, Inc. (RANI) KPIs and segments
RANINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 2/3044% above fair value
$0.53+0.00 (+0.21%)
Close on Nov 13, 2026Market cap $73.36MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Rani Therapeutics's business
Coming soon
This tab will track the numbers specific to Rani Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?